News

Modern healthcare is increasingly reliant on genetic testing. Its significance is at an all-time high due to its applications ...
AssistIQ said today it closed an all-primary, all-equity $11.5 million Series A round in April, led by Boston-based Battery Ventures, with participation from return investor Tamarind Hill. It raised a ...
NeoGenomics will debut its PanTracer Family and unveil the Paletrra platform at ASCO 2025, advancing precision oncology ...
The answers to some of medicine's biggest challenges are hiding in the rarest of diseases. A new podcast from Pacific ...
The Global Life Science Consulting Services Market is expected to witness a growth rate of 10% in the next five ...
Dark genome therapeutics market is poised for robust growth through 2035, driven by increasing demand for personalized medicine and genomic advances.
UK genomics tools developer RevoluGen has signed a distribution agreement with Hong Kong-based life sciences supplier ...
Advances in nanotechnology lead to an investigation of how the structures engineered with nanomaterials interact with ...
In a leap forward for genetic and biomedical research, two scientists at the University of Missouri have developed a powerful ...
Detailed price information for GX Genomics & Biotechnology ETF (GNOM-Q) from The Globe and Mail including charting and trades.